Gossamer Historical Balance Sheet
GOSS Stock | USD 0.70 0.04 6.06% |
Trend analysis of Gossamer Bio balance sheet accounts such as Other Current Liabilities of 24.6 M or Total Current Liabilities of 32.7 M provides information on Gossamer Bio's total assets, liabilities, and equity, which is the actual value of Gossamer Bio to its prevalent stockholders. By breaking down trends over time using Gossamer Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Gossamer Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gossamer Bio is a good buy for the upcoming year.
Gossamer Bio Inventory |
|
Gossamer |
About Gossamer Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Gossamer Bio at a specified time, usually calculated after every quarter, six months, or one year. Gossamer Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Gossamer Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Gossamer currently owns. An asset can also be divided into two categories, current and non-current.
Gossamer Bio Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Gossamer Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Gossamer Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Gossamer Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Gossamer Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Long Term Debt
Long-term debt is a debt that Gossamer Bio has held for over one year. Long-term debt appears on Gossamer Bio balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Gossamer Bio balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from Gossamer Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.At this time, Gossamer Bio's Net Working Capital is comparatively stable compared to the past year. Property Plant And Equipment Net is likely to gain to about 8.1 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 134 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 185.2M | 225.7M | 212.5M | 134.0M | Total Assets | 343.7M | 272.5M | 311.9M | 293.4M |
Gossamer Bio balance sheet Correlations
Click cells to compare fundamentals
Gossamer Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gossamer Bio balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 426.6M | 539.4M | 343.7M | 272.5M | 311.9M | 293.4M | |
Other Current Liab | 33.6M | 27.5M | 33.7M | 33.2M | 31.2M | 24.6M | |
Total Current Liabilities | 36.9M | 38.7M | 39.9M | 49.2M | 51.6M | 32.7M | |
Total Stockholder Equity | (334.2M) | (577.5M) | (811.5M) | (1.0B) | 62.8M | 65.9M | |
Net Tangible Assets | 352.5M | 320.7M | 121.5M | 12.1M | 13.9M | 13.2M | |
Net Debt | (95.5M) | (302.3M) | 1.8M | 113.8M | 180.4M | 189.4M | |
Retained Earnings | (334.2M) | (577.5M) | (811.5M) | (1.0B) | (1.2B) | (1.2B) | |
Accounts Payable | 956K | 7.5M | 3.2M | 1.5M | 5.5M | 2.9M | |
Cash | 135.1M | 486.1M | 183.4M | 112.0M | 32.1M | 30.5M | |
Non Current Assets Total | 17.3M | 17.1M | 11.9M | 10.6M | 5.4M | 9.6M | |
Non Currrent Assets Other | 1.6M | 1.0M | 1.1M | 680K | 618K | 923.7K | |
Cash And Short Term Investments | 401.8M | 512.6M | 325.2M | 255.7M | 296.4M | 277.9M | |
Common Stock Shares Outstanding | 54.7M | 68.5M | 74.8M | 84.6M | 152.6M | 160.3M | |
Short Term Investments | 266.7M | 26.6M | 141.8M | 143.7M | 264.3M | 132.9M | |
Liabilities And Stockholders Equity | (260.1M) | (358.8M) | (589.3M) | (771.9M) | 311.9M | 327.5M | |
Non Current Liabilities Total | 37.2M | 180.1M | 182.3M | 211.1M | 197.5M | 158.6M | |
Total Liab | 74.1M | 218.7M | 222.2M | 260.4M | 249.1M | 191.3M | |
Total Current Assets | 409.3M | 522.3M | 331.8M | 261.9M | 306.5M | 283.8M | |
Capital Surpluse | 686.4M | 897.6M | 932.9M | 1.0B | 1.2B | 659.2M | |
Other Current Assets | 7.5M | 9.7M | 6.6M | 12.4M | 10.1M | 7.8M | |
Other Stockholder Equity | (426.9M) | 897.6M | 932.9M | 1.0B | 1.3B | 1.3B | |
Net Invested Capital | 380.9M | 493.1M | 300.6M | 231.4M | 271.8M | 244.7M | |
Net Working Capital | 372.4M | 483.7M | 291.9M | 212.7M | 254.9M | 287.0M | |
Property Plant And Equipment Net | 15.7M | 16.1M | 10.8M | 9.9M | 4.8M | 8.1M | |
Other Assets | 1.6M | 1.0M | 1.1M | 680K | 1.0 | 0.95 | |
Property Plant And Equipment Gross | 15.7M | 16.1M | 15.1M | 16.0M | 10.2M | 14.0M | |
Accumulated Other Comprehensive Income | 258K | 599K | 45K | (574K) | (350K) | (332.5K) | |
Property Plant Equipment | 15.7M | 5.5M | 5.3M | 4.0M | 3.6M | 5.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.